Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Douglas R. Adkins, Loren S. Michel et al.|Clinical Cancer Research|2020Cited by 368
High-Risk Human Papillomavirus E6/E7 mRNA Detection by a Novel In Situ Hybridization Assay Strongly Correlates With p16 Expression and Patient Outcomes in Oropharyngeal Squamous Cell CarcinomaOdey C. Ukpo, James S. Lewis, John J. Flanagan et al.|The American Journal of Surgical Pathology|2011Cited by 292
Transcriptionally‐active high‐risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas – a tissue microarray study utilizing E6/E7 mRNA <i>in situ</i> hybridizationJames S. Lewis, Rebecca D. Chernock, Odey C. Ukpo et al.|Histopathology|2012Cited by 112
A novel RT‐PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosisGe Gao, Xiaowei Wang, Rebecca D. Chernock et al.|International Journal of Cancer|2012Cited by 100
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Douglas R. Adkins, Katie M. Campbell et al.|Clinical Cancer Research|2021Cited by 14